Capturing cell morphology dynamics with high temporal resolution using single-shot quantitative phase gradient imaging
Hur, Sun Woong, Kwon, Minsung, Manoharaan, Revathi, Mohammadi, Melika Haji, Samuel, Ashok Zachariah, Mulligan, Michael P, Hergenrother, Paul J, Bhargava, Rohit
Published in Journal of biomedical optics (01.06.2024)
Published in Journal of biomedical optics (01.06.2024)
Get full text
Journal Article
Activators of the Anticipatory Unfolded Protein Response with Enhanced Selectivity for Estrogen Receptor Positive Breast Cancer
Boudreau, Matthew W, Mulligan, Michael P, Shapiro, David J, Fan, Timothy M, Hergenrother, Paul J
Published in Journal of medicinal chemistry (10.03.2022)
Published in Journal of medicinal chemistry (10.03.2022)
Get full text
Journal Article
An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with In Vivo Efficacy against Drug-Resistant Gram-Negative Infections
Parker, Erica N., Cain, Brett N., Hajian, Behnoush, Ulrich, Rebecca J., Geddes, Emily J., Barkho, Sulyman, Lee, Hyang Yeon, Williams, John D., Raynor, Malik, Caridha, Diana, Zaino, Angela, Shekhar, Mrinal, Muñoz, Kristen A., Rzasa, Kara M., Temple, Emily R., Hunt, Diana, Jin, Xiannu, Vuong, Chau, Pannone, Kristina, Kelly, Aya M., Mulligan, Michael P., Lee, Katie K., Lau, Gee W., Hung, Deborah T., Hergenrother, Paul J.
Published in ACS central science (24.08.2022)
Published in ACS central science (24.08.2022)
Get full text
Journal Article
Synthesis, conformational preferences, and biological activity of conformational analogues of the microtubule-stabilizing agents, (−)-zampanolide and (−)-dactylolide
Henry, Jeffrey L, Wilson, Matthew R, Mulligan, Michael P, Quinn, Taylor R, Sackett, Dan L, Taylor, Richard E
Published in MedChemComm (01.05.2019)
Published in MedChemComm (01.05.2019)
Get full text
Journal Article
Correction to “An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with In Vivo Efficacy against Drug-Resistant Gram-Negative Infections”
Parker, Erica N., Cain, Brett N., Hajian, Behnoush, Ulrich, Rebecca J., Geddes, Emily J., Barkho, Sulyman, Lee, Hyang Yeon, Williams, John D., Raynor, Malik, Caridha, Diana, Zaino, Angela, Rohde, Jason M., Zak, Mark, Shekhar, Mrinal, Muñoz, Kristen A., Rzasa, Kara M., Temple, Emily R., Hunt, Diana, Jin, Xiannu, Vuong, Chau, Pannone, Kristina, Kelly, Aya M., Mulligan, Michael P., Lee, Katie K., Lau, Gee W., Hung, Deborah T., Hergenrother, Paul J.
Published in ACS central science (28.09.2022)
Published in ACS central science (28.09.2022)
Get full text
Journal Article
Abstract 522: Selective estrogen receptor a-UPR activators (SERA): a novel class of small molecules that eradicate estrogen receptor positive tumors
Mulligan, Michael P., Boudreau, Matthew W., Shapiro, David J., Fan, Timothy M., Hergenrother, Paul J., Barnhart, Kerry, Azorsa, David, Kiefer, Jeff, Mousses, Spyro
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article
Synthesis, conformational preferences, and biological activity of conformational analogues of the microtubule-stabilizing agents, (–)-zampanolide and (–)-dactylolide† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c9md00164f
Henry, Jeffrey L., Wilson, Matthew R., Mulligan, Michael P., Quinn, Taylor R., Sackett, Dan L., Taylor, Richard E.
Published in MedChemComm (09.04.2019)
Published in MedChemComm (09.04.2019)
Get full text
Journal Article